These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25354180)

  • 1. Chemistry, physiology, and pharmacology of β-adrenergic mechanisms in the heart. Why are β-blocker antiarrhythmics superior?
    Szentmiklosi AJ; Szentandrássy N; Hegyi B; Horvath B; Magyar J; Bányász T; Nanasi PP
    Curr Pharm Des; 2015; 21(8):1030-41. PubMed ID: 25354180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic mechanisms of beta blocker therapy.
    Grandi E; Ripplinger CM
    Pharmacol Res; 2019 Aug; 146():104274. PubMed ID: 31100336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockers as antiarrhythmic agents.
    Zicha S; Tsuji Y; Shiroshita-Takeshita A; Nattel S
    Handb Exp Pharmacol; 2006; (171):235-66. PubMed ID: 16610347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors].
    Witkowska M
    Kardiol Pol; 1982; 25(2):147-61. PubMed ID: 6125621
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiarrhythmic action of beta-blockers: potential mechanisms.
    Dorian P
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S15-22. PubMed ID: 15965568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical use of beta-blocker an as antiarrhythmic agent].
    Okazaki O; Akatsuka N
    Nihon Rinsho; 1996 Aug; 54(8):2117-24. PubMed ID: 8810786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta blockers as anti-arrhythmic agents.
    Anh D; Marine JE
    Heart Fail Rev; 2004 Apr; 9(2):139-47. PubMed ID: 15516862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current classification of anti-arrhythmia agents].
    Weirich J; Wenzel W
    Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, cardiac electrophysiology, and beta-blocking activity of novel arylpiperazines with potential as class II/III antiarrhythmic agents.
    Phillips GB; Morgan TK; Lumma WC; Gomez RP; Lind JM; Lis R; Argentieri T; Sullivan ME
    J Med Chem; 1992 Feb; 35(4):743-50. PubMed ID: 1347318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of antiarrhythmic drugs in elderly patients.
    Frishman WH; Aronow WS
    Clin Geriatr Med; 2012 Nov; 28(4):575-615. PubMed ID: 23101572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenoceptor blockade: electrophysiology and antiarrhythmic mechanisms.
    Sung RJ; Tai DY; Svinarich JT
    Am Heart J; 1984 Oct; 108(4 Pt 2):1115-20. PubMed ID: 6148871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenoceptor blocker treatment and the cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure.
    Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Feb; 374(5-6):361-72. PubMed ID: 17216434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic action of adrenergic beta-receptor blocking agents.
    Seth SD
    Pharmacol Ther; 1980; 11(1):159-79. PubMed ID: 6107939
    [No Abstract]   [Full Text] [Related]  

  • 15. A fresh look at cardiac arrhythmias. Therapy.
    Krikler DM
    Lancet; 1974 May; 1(7865):1034-7. PubMed ID: 4133713
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
    Yu XC; Wang HX; Pei JM; Wong TM
    J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic drugs: electrophysiological basis of their clinical usage.
    Weng JT; Smith DE; Moulder PV
    Ann Thorac Surg; 1986 Jan; 41(1):106-12. PubMed ID: 2417568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic activity and antiarrhythmic efficacy of CK-3579, a new class III antiarrhythmic agent with beta-adrenergic blocking properties.
    Argentieri TM; Troy HH; Carroll MS; Doroshuk CM; Sullivan ME
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):647-55. PubMed ID: 7681912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
    Lazzara R
    Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General principles of antiarrhythmic therapy for ventricular tachyarrhythmias.
    Landers MD; Reiter MJ
    Am J Cardiol; 1997 Oct; 80(8A):31G-44G. PubMed ID: 9354410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.